Authors
Latest:
Unlocking health mysteriesResearchers find a strong link between Alzheimer's disease and retinal thinning
Latest:
Patient outcomes and intraoperative use of phenylephrine/ketorolac 1%/0.3%ICYMI: Denise Visco, MD, shares the take-home message from her 2019 ASCRS presentation.
Latest:
Neuropathic dry eye: When serum defeats tearsOphthalmology Times is pleased to announce Melina I. Morkin, MD, and Pedram Hamrah, MD, FACS, of New England Eye Center/Tufts Medical Center, Department of Ophthalmology, Tufts University School of Medicine, Boston, as the third-place winner of the 2017 Resident Writer’s Award Program, sponsored by Allergan. Their entry is featured here.
Latest:
Neuropathic dry eye: When serum defeats tearsOphthalmology Times is pleased to announce Melina I. Morkin, MD, and Pedram Hamrah, MD, FACS, of New England Eye Center/Tufts Medical Center, Department of Ophthalmology, Tufts University School of Medicine, Boston, as the third-place winner of the 2017 Resident Writer’s Award Program, sponsored by Allergan. Their entry is featured here.
Latest:
Cyclosporine for dry eye associated with anti-PD-1 therapyTopical cyclosporine may be useful for treating dry eyes associated with immunomodulatory agents like nivolumab, which markedly upregulate T cell activation. In caring for patients with ocular side effects associated with cancer treatment, the delivery of proper ophthalmic care is critical.
Latest:
Cyclosporine for dry eye associated with anti-PD-1 therapyTopical cyclosporine may be useful for treating dry eyes associated with immunomodulatory agents like nivolumab, which markedly upregulate T cell activation. In caring for patients with ocular side effects associated with cancer treatment, the delivery of proper ophthalmic care is critical.
Latest:
Assessing the severity of Fuchs’ endothelial corneal dystrophy by using Scheimpflug tomographyInvestigators sought to develop a severity scale for tomographic edema in FECD based on Scheimpflug tomography maps, and to evaluate intra- and inter-observer variation for assessing severity.
Latest:
Integrating computer-assisted toric IOL implantationSince making the switch to a markerless toric alignment system, Bryan S. Lee, MD, JD, explains how the technology has eliminated ink marking from his surgical regimen.
Latest:
Irritation in a bottle: Glaucoma and OSDOSD is of significant concern in patients with glaucoma on multiple topical medications. Optimal treatment of this condition with minimizing the intensity as well as with additional pharmacologic treatments for OSD can improve visual acuity and compliance and result in better outcomes both medically and regarding patient satisfaction.
Latest:
Approaches to Selecting MIGS for Individualizing Glaucoma ManagementDr. Khouri discusses the MIGS procedures he performs in his practice and his approach to selecting the most appropriate procedure for each patient.
Latest:
Let's be social: Making Facebook connections workOne mistake ophthalmologists typically make with Facebook is to presume their practice websites and Facebook pages should contain similar information. Another misperception is that Facebook is a platform for the constant promotion of their specials, procedures, or new technologies in eye care.
Latest:
Work of eye bank network shows far-reaching impactIn 2016, Vision Share eye banks provided more than half the supply of U.S. donor corneas with over 20,000 placements. It has worked to build the largest network of non-profit eye banks in the world, with 13 members and 20 eye banks in the United States and a vast network of providers at home and abroad.
Latest:
Don’t practice what I preachRecent surveys across most medical specialties confirm physicians in active practice preach to themselves and their patients about the fulfillment of providing intimate, life-improving care, but advise their children to avoid becoming physicians.
Latest:
Study offering new hope for medical presbyopia correctionBRIO-1 clinical trial sowing optimism as a potential therapeutic option.
Latest:
Micro-instrumentation reduces trauma in IOL exchangeIncreased procedure volume and patient expectations have made IOL exchange procedures more common. Smaller incisions and the need to reduce trauma require new micro-instrumentation for best outcomes.
Latest:
Unconventional timesWhether one agrees or disagrees with President Donald J. Trump, we can agree that part of his success was finding a way to skip the media, go around the career politicians, and go directly to the people. Is it possible that our legislative efforts have borne so little fruit because we’ve approached it as a politician would?
Latest:
How pattern, flicker ERG can impact cataract treatment decisionsRetinal issues can impact cataract surgery outcomes, especially for those with multifocal or other premium lenses. While multifocal lenses may allow the patient to see more clearly across a range of distances, they may also decrease the amount of light that reaches the retina, exacerbating any issues that may already be present.
Latest:
The need for precision management in glaucoma moves field forwardGenotyping and artificial intelligence are together starting to predict the progression of glaucoma in individual patients, sparing them from suboptimal treatments and adverse effects. Recent research efforts are exploring modifiable risk factors such as caffeine consumption.
Latest:
Early surgical intervention with stent advantageous for certain glaucomasIt is well known that with most disease, the earlier it is detected, the better the outcome prognosis. Along with early detection comes the need for early treatment. Traditionally, options for glaucoma have been limited. Medications can be effective when used properly, though patients are notorious for compliance issues.
Latest:
Laser trabeculoplasty suitable for all open-angle glaucoma patientsProstaglandin-based topical therapy has been the ‘go-to treatment’ for open-angle glaucoma for decades. In contrast, laser trabeculoplasty has conventionally remained reserved for patients unresponsive or unable to adhere to medication-based therapy.
Latest:
The importance of being honestOne of the biggest challenges for ophthalmologists, especially in the field of refractive surgery, is to define ourselves (in professional terms) and set our goals.
Latest:
ABiC viable option for different stages severities of glaucomaWith its ability to restore the eye’s natural outflow pathway, ab-interno canaloplasty (ABiC) presents a viable option for the treatment of different stages and severities of glaucoma, according to Mark J. Gallardo, MD.
Latest:
Flexible glaucoma procedure serves wide variety of patientsJuan Carlos Izquierdo, MD, decribes how CO2 laser-assisted sclerectomy surgery is a successful, less invasive, and more simple option for a wide range of glaucoma patients. Due to his overall success with the CLASS procedure, he no longer performs trabeculectomy.
Latest:
PANTHER Study offers 1-year results for fluocinolone acetonide intravitreal implantThe study investigates 3-year intravitreal implant in eyes with active noninfectious posterior uveitis.
Latest:
Adding electroretinography: Technology to clinical utilityPattern electroretinography (PERG) and visually evoked potential (VEP) tests can objectively evaluate the function of axion and retinal ganglion cells. These test results can add another component in successfully treating patients with cataract and/or glaucoma.
Latest:
Why ophthalmologists are easy prey for cybercriminalsA perfect storm is brewing that may make ophthalmologists and office staff, with networked equipment, easy targets for cyber criminals. In a matter of days, cyber criminals can infect computers around the world. Sure, you can pay the ransom, but HIPAA fines and consultant fees, recovering from the damage to your reputation, loss of patients, and all the time and energy lost could bankrupt your practice.
